Cuorips Inc.

4894.T
Biotechnology
2026/01/16 Updated
Market Cap: $449.0M (¥71.1B)
Stock Price: $54.46 (¥8,630)
Exchange Rate: 1 USD = ¥158.48

Stock Price Chart

2026/01/16 Updated
0.00
PER (Price Earnings Ratio)
vs Industry Avg: -9.6
13.58
PBR (Price to Book Ratio)
vs Industry Avg: +12.3
0.00%
Dividend Yield
vs Industry Avg: -2.95%

Price Trend

2026/01/16 Updated
Short-term
5-Day MA
+11.18%
Near-term
25-Day MA
+34.47%
Mid-term
75-Day MA
+31.98%
Long-term
200-Day MA
+29.46%

Price & Trading Details

2026/01/16 Updated

PRICE

Previous Close ¥8,100
Open ¥8,000
High ¥8,700
Low ¥7,920
Close ¥8,630

TRADING

Volume 327,900
Average Volume 89,174
Turnover ¥28億
Min. Purchase ¥863,000

Financial Performance

2026/01/11 Updated

No financial data available

Latest IR Information

  • No IR information found for this company.

    Searched stock code: 4894

Latest News (5 items)

Company Information

English Name Cuorips Inc.
Japanese Name クオリプス(株)
Stock Code 4894.T (JPX)
Sector / Industry Healthcare / Biotechnology
Website https://cuorips.co.jp
Employees 56

About

Cuorips Inc. engages in the research, development, manufacture, commercialization, and sale of human iPS cell-derived cardiomyocyte sheets. The company offers cellular and tissue-based, and cell processing products. It also provides contract development and manufacturing, and consulting services. The company was formerly known as Cuore Inc. and changed its name to Cuorips Inc. in June 2017. Cuorips Inc. was incorporated in 2017 and is headquartered in Tokyo, Japan.

Data provided by Yahoo Finance